The objective of this proof-of-concept pilot study is to evaluate Donepezil HCL (Aricept) for
side effects and effects on smoking behavior and performance on neurocognitive tasks in a
population of dependent smokers.
Phase:
Phase 2
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania